Goldman Sachs Group »

Eupraxia Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $237k 40k 5.90
2025-03-31 $113k 35k 3.28
2024-12-31 $109k 35k 3.17
2024-09-30 $91k 35k 2.63